[1]Cervellati C, Trentini A, Pecorelli A, et al. Inflammation in neurological disorders: the thin boundary between brain and periphery[J]. Antioxid Redox Signal, 2020,33:191-210. [2]李佳蕊. 神经炎症反应在动物创伤性脑损伤中的研究进展[J]. 国际神经病学神经外科学杂志, 2019, 46:214-217. [3]翟茜, 贾济, 王强. 髓样细胞激发受体-2在中枢神经系统疾病中的研究进展[J]. 国际麻醉学与复苏杂志, 2015, 36:382-385. [4]Zheng H, Cheng B, Li Y, et al. TREM2 in Alzheimer's disease: microglial survival and energy metabolism[J]. Front Aging Neurosci, 2018,10:395. doi: 10.3389/fnagi.2018.00395. [5]Zhong L, Chen XF, Wang T, et al. Soluble TREM2 induces inflammatory responses and enhances microglial survival[J]. J Exp Med, 2017,214:597-607. [6]冉江霞,石胜良,王成志.TREM2基因过表达慢病毒载体的构建及其表达的研究[J]. 广西医科大学学报,2018,35:22-26. [7]柴慈婧, 涂悦,张启财,等.抗tau蛋白抗体基因疗法对慢性颅脑创伤的治疗作用研究[J].中华神经创伤外科电子杂志, 2020,5:292-298. [8]Stephenson J, Nutma E, van der Valk P, et al. Inflammation in CNS neurodegenerative diseases[J]. Immunology, 2018,154:204-219. [9]Mendiola AS, Cardona AE. The IL-1β phenomena in neuroinflammatory diseases[J]. J Neural Transm (Vienna), 2018,125:781-795. [10]Ben-Ari H, Lifschytz T, Wolf G, et al. White matter lesions, cerebral inflammation and cognitive function in a mouse model of cerebral hypoperfusion[J]. Brain Res, 2019,1711:193-201. [11]Zhou J, Yu W, Zhang M, et al. Imbalance of microglial TLR4/TREM2 in LPS-treated APP/PS1 transgenic mice: a potential link between Alzheimer's disease and systemic Inflammation[J]. Neurochem Res, 2019,44:1138-1151. [12]Yang H, Wang L, Zang C, et al. Src inhibition attenuates neuroinflammation and protects dopaminergic neurons in Parkinson's disease models[J]. Front Neurosci, 2020,14:45. doi: 10.3389/fnins.2020.00045. [13]Xu S, Lu J, Shao A, et al. Glial cells: role of the immune response in ischemic stroke[J]. Front Immunol, 2020,11:294. doi: 10.3389/fimmu.2020.00294. [14]Yao K, Zu HB. Microglial polarization: novel therapeutic mechanism against Alzheimer's disease[J]. Inflammopharmacology, 2020,28:95-110. [15]Jiang T, Zhang YD, Chen Q, et al. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice[J]. Neuropharmacology, 2016,105:196-206. [16]Zhong L, Xu Y, Zhuo R, et al. Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease model[J]. Nat Commun, 2019,10:1365. doi: 10.1038/s41467-019-09118-9. |